LAZERTINIB

LAZERTINIB was reported 865 times

LAZERTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LARYNGEAL WEB 2 0.1333
1 SCROTUM EROSION 1 0.0500
2 EROSIVE PUSTULAR DERMATOSIS 2 0.0400
3 CONJUNCTIVAL GRANULOMA 1 0.0345
4 KERATOLYSIS EXFOLIATIVA ACQUIRED 1 0.0312
5 TRICHOMEGALY 1 0.0227
6 NAIL TOXICITY 5 0.0167
7 PARONYCHIA 69 0.0157
8 NAIL CUTICLE FISSURE 1 0.0152
9 ACTINIC ELASTOSIS 1 0.0132
10 ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED 1 0.0116
11 LUNG ADENOCARCINOMA RECURRENT 1 0.0097
12 PINGUECULA 1 0.0094
13 HAEMATOSPERMIA 6 0.0087
14 ANAL ULCER 7 0.0086
15 NAIL DISCOMFORT 1 0.0083
16 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
17 NON-SMALL CELL LUNG CANCER RECURRENT 2 0.0071
18 ACUTE CARDIAC EVENT 1 0.0058
19 ADMINISTRATION RELATED REACTION 1 0.0051
20 DERMATITIS ACNEIFORM 31 0.0051
21 EXSANGUINATION 1 0.0050
22 PITUITARY ENLARGEMENT 1 0.0049
23 PRODUCT ADMINISTRATION ISSUE 1 0.0048
24 SKIN TOXICITY 27 0.0048
25 GASTRODUODENAL ULCER 2 0.0048
26 ZINC DEFICIENCY 1 0.0047
27 OCULAR TOXICITY 5 0.0045
28 RENAL CYST HAEMORRHAGE 1 0.0044
29 STOMA OBSTRUCTION 1 0.0044
30 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
31 PYOGENIC GRANULOMA 2 0.0043
32 SCROTAL ULCER 1 0.0038
33 XERODERMA 1 0.0037
34 INTERTRIGO 2 0.0037
35 CATHETER SITE THROMBOSIS 1 0.0036
36 PALPABLE PURPURA 1 0.0036
37 GASTROINTESTINAL OEDEMA 6 0.0034
38 CORNEA VERTICILLATA 1 0.0033
39 TRICHIASIS 1 0.0031
40 NAIL BED INFLAMMATION 1 0.0031
41 HYPOALBUMINAEMIA 24 0.0031
42 EMBOLISM VENOUS 9 0.0030
43 HEAT ILLNESS 2 0.0030
44 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
45 CONJUNCTIVAL DISORDER 1 0.0026
46 CREATINE KINASE INCREASED 2 0.0026
47 COAGULATION TEST ABNORMAL 2 0.0026
48 SKIN ULCER HAEMORRHAGE 1 0.0026
49 CARDIOVASCULAR SYMPTOM 1 0.0026
50 LARYNGEAL PAIN 1 0.0025
51 VULVAL ABSCESS 1 0.0024
52 USE OF ACCESSORY RESPIRATORY MUSCLES 1 0.0024
53 VAGINAL ULCERATION 1 0.0024
54 NON-SMALL CELL LUNG CANCER 11 0.0023
55 CRANIAL NERVE PARALYSIS 1 0.0021
56 GENITAL RASH 3 0.0021
57 NAIL INFECTION 3 0.0021
58 BLOOD CREATINE ABNORMAL 1 0.0021
59 MUCOSAL DISORDER 2 0.0020
60 RENAL HAEMATOMA 1 0.0019
61 OEDEMA MUCOSAL 2 0.0019
62 RADIATION PNEUMONITIS 4 0.0019
63 HYPEREOSINOPHILIC SYNDROME 1 0.0018
64 HYPERAMYLASAEMIA 1 0.0018
65 OESOPHAGEAL IRRITATION 1 0.0017
66 BLOOD ALBUMIN DECREASED 13 0.0016
67 XEROSIS 2 0.0016
68 NASAL CRUSTING 1 0.0015
69 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
70 RENAL SURGERY 1 0.0015
71 HIRSUTISM 2 0.0015
72 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
73 EFFUSION 2 0.0015
74 OESOPHAGITIS ULCERATIVE 1 0.0015
75 INFUSION RELATED REACTION 96 0.0014
76 ANGULAR CHEILITIS 1 0.0014
77 PEPTIC ULCER HAEMORRHAGE 1 0.0014
78 NONINFECTIVE ENCEPHALITIS 1 0.0014
79 INFUSION SITE REACTION 4 0.0013
80 METAPNEUMOVIRUS INFECTION 1 0.0013
81 GROWTH OF EYELASHES 1 0.0013
82 ABDOMINAL SYMPTOM 1 0.0012
83 TONGUE ERYTHEMA 1 0.0012
84 SYNDACTYLY 1 0.0012
85 CRANIOFACIAL FRACTURE 1 0.0012
86 PHYSICAL DECONDITIONING 3 0.0012
87 PULMONARY TOXICITY 8 0.0011
88 AMYLASE INCREASED 4 0.0011
89 SMALL INTESTINAL PERFORATION 2 0.0011
90 CARCINOEMBRYONIC ANTIGEN INCREASED 2 0.0010
91 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
92 DUODENAL PERFORATION 1 0.0010
93 SKIN EROSION 3 0.0009
94 LISTLESS 3 0.0009
95 TINEA INFECTION 1 0.0009
96 GASTROINTESTINAL ULCER 2 0.0009
97 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
98 METASTASES TO MENINGES 2 0.0009
99 MUCOSAL HAEMORRHAGE 1 0.0009
100 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
101 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
102 THROMBOPHLEBITIS 3 0.0009
103 SENSE OF OPPRESSION 1 0.0008
104 INGROWING NAIL 2 0.0008
105 FIBRIN D DIMER INCREASED 3 0.0008
106 URINE OUTPUT INCREASED 2 0.0008
107 TONGUE DRY 1 0.0007
108 LIP BLISTER 2 0.0007
109 RHINALGIA 2 0.0007
110 PRERENAL FAILURE 1 0.0007
111 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
112 INVESTIGATION ABNORMAL 1 0.0007
113 SKIN DISORDER 23 0.0007
114 JUDGEMENT IMPAIRED 1 0.0007
115 PANCREATIC ENZYMES INCREASED 1 0.0007
116 BILIARY DILATATION 1 0.0007
117 COCCYDYNIA 1 0.0007
118 SMALL CELL LUNG CANCER 1 0.0007
119 PNEUMONITIS 18 0.0007
120 PERFORMANCE STATUS DECREASED 3 0.0006
121 DRUG ERUPTION 11 0.0006
122 INJECTION RELATED REACTION 1 0.0006
123 SEBORRHOEIC DERMATITIS 1 0.0006
124 CEREBELLAR INFARCTION 1 0.0006
125 EROSIVE OESOPHAGITIS 1 0.0006
126 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
127 EXTREMITY NECROSIS 1 0.0006
128 PURPURA 5 0.0006
129 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
130 INDURATION 1 0.0006
131 NEUROPATHY PERIPHERAL 53 0.0006
132 PNEUMOMEDIASTINUM 1 0.0006
133 TETANY 1 0.0005
134 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
135 STOMATITIS 32 0.0005
136 MYELOPATHY 1 0.0005
137 SCAB 6 0.0005
138 HYPERCOAGULATION 1 0.0005
139 ARTERIAL THROMBOSIS 1 0.0005
140 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
141 PURULENCE 1 0.0005
142 UNDERWEIGHT 1 0.0005
143 EAR HAEMORRHAGE 1 0.0005
144 SHOCK HAEMORRHAGIC 4 0.0005
145 INTRAMEDULLARY ROD INSERTION 1 0.0005
146 CAPILLARY LEAK SYNDROME 1 0.0005
147 EMBOLISM 4 0.0005
148 FOLLICULITIS 5 0.0005
149 SLEEP DEFICIT 1 0.0005
150 HYPERPHOSPHATAEMIA 1 0.0005
151 CORNEAL DISORDER 1 0.0005
152 DANDRUFF 1 0.0005
153 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
154 POSTOPERATIVE WOUND INFECTION 3 0.0004
155 ONYCHOCLASIS 3 0.0004
156 HAIR GROWTH ABNORMAL 3 0.0004
157 SKIN REACTION 6 0.0004
158 DUODENAL ULCER 3 0.0004
159 SKIN TIGHTNESS 2 0.0004
160 OEDEMA 23 0.0004
161 PUSTULE 1 0.0004
162 RASH VESICULAR 2 0.0004
163 RASH PUSTULAR 3 0.0004
164 SKIN FRAGILITY 1 0.0004
165 CYTOPENIA 5 0.0004
166 ORGANISING PNEUMONIA 2 0.0004
167 HEPATIC FUNCTION ABNORMAL 15 0.0004
168 INTERSTITIAL LUNG DISEASE 19 0.0004
169 SKIN NECROSIS 2 0.0004
170 ULCER 6 0.0004
171 ADVERSE REACTION 5 0.0004
172 ANAL FISSURE 2 0.0004
173 PRODUCT SIZE ISSUE 2 0.0004
174 RASH 162 0.0004
175 PRODUCT RESIDUE PRESENT 2 0.0004
176 MACULE 1 0.0004
177 HAEMORRHOIDS 7 0.0004
178 RENAL TUBULAR DISORDER 1 0.0004
179 TUMOUR HAEMORRHAGE 1 0.0004
180 DUODENAL ULCER HAEMORRHAGE 1 0.0003
181 RETINAL VEIN OCCLUSION 1 0.0003
182 BLOOD MAGNESIUM DECREASED 3 0.0003
183 SKIN ATROPHY 2 0.0003
184 PARAPLEGIA 1 0.0003
185 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
186 HYPERTRIGLYCERIDAEMIA 2 0.0003
187 TOOTH DISCOLOURATION 1 0.0003
188 SKIN HAEMORRHAGE 5 0.0003
189 ATYPICAL PNEUMONIA 1 0.0003
190 POLYNEUROPATHY 4 0.0003
191 DYSCHEZIA 1 0.0003
192 PIGMENTATION DISORDER 2 0.0003
193 BLOOD BLISTER 1 0.0003
194 NON-CARDIAC CHEST PAIN 1 0.0003
195 HEPATOTOXICITY 7 0.0003
196 PROCTALGIA 2 0.0003
197 SKIN FISSURES 6 0.0003
198 DEAFNESS NEUROSENSORY 1 0.0003
199 NEOPLASM RECURRENCE 1 0.0003
200 WOUND COMPLICATION 1 0.0003
201 GRANULOMA 1 0.0003
202 LARGE INTESTINE PERFORATION 2 0.0003
203 HYPERTRANSAMINASAEMIA 2 0.0003
204 DERMATITIS 6 0.0003
205 SKIN WEEPING 1 0.0003
206 BONE LESION 1 0.0003
207 LEUKOENCEPHALOPATHY 1 0.0003
208 SUNBURN 2 0.0003
209 MUCOSAL INFLAMMATION 7 0.0003
210 PROTEIN TOTAL DECREASED 1 0.0003
211 LIPASE INCREASED 2 0.0003
212 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
213 EPIGASTRIC DISCOMFORT 1 0.0003
214 NAIL DISCOLOURATION 1 0.0003
215 GINGIVAL PAIN 2 0.0003
216 AZOTAEMIA 1 0.0003
217 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
218 BLEPHARITIS 1 0.0002
219 OXYGEN SATURATION DECREASED 14 0.0002
220 DEEP VEIN THROMBOSIS 16 0.0002
221 BUNDLE BRANCH BLOCK LEFT 1 0.0002
222 SKIN ULCER 6 0.0002
223 CHAPPED LIPS 1 0.0002
224 IMMOBILE 1 0.0002
225 NAIL DISORDER 2 0.0002
226 MELAENA 5 0.0002
227 PANCREATITIS ACUTE 5 0.0002
228 OEDEMA PERIPHERAL 27 0.0002
229 SUSPECTED OFF LABEL USE 1 0.0002
230 TUMOUR MARKER INCREASED 1 0.0002
231 GASTROINTESTINAL TOXICITY 1 0.0002
232 DIZZINESS POSTURAL 2 0.0002
233 ORAL HERPES 4 0.0002
234 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
235 RENAL CELL CARCINOMA 1 0.0002
236 HYPERNATRAEMIA 1 0.0002
237 PATHOLOGICAL FRACTURE 1 0.0002
238 HYPERBILIRUBINAEMIA 2 0.0002
239 APLASTIC ANAEMIA 1 0.0002
240 PRODUCT USE COMPLAINT 3 0.0002
241 METASTASES TO BONE 3 0.0002
242 SKIN LESION 5 0.0002
243 INTESTINAL ISCHAEMIA 1 0.0002
244 STEVENS-JOHNSON SYNDROME 4 0.0002
245 DRY SKIN 24 0.0002
246 MALNUTRITION 2 0.0002
247 SKIN INFECTION 2 0.0002
248 INTESTINAL PERFORATION 2 0.0002
249 PERIORBITAL SWELLING 1 0.0002
250 CHOLECYSTITIS ACUTE 1 0.0002
251 SKIN IRRITATION 8 0.0002
252 MOUTH SWELLING 1 0.0002
253 ENTEROCOLITIS 1 0.0002
254 VASCULITIS 2 0.0002
255 PRODUCT LABEL CONFUSION 1 0.0002
256 HYPERKALAEMIA 6 0.0002
257 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
258 PULMONARY EMBOLISM 16 0.0002
259 PLEURAL EFFUSION 10 0.0002
260 CHOLANGITIS 1 0.0002
261 INFUSION SITE EXTRAVASATION 1 0.0002
262 EPISTAXIS 12 0.0002
263 DRUG-INDUCED LIVER INJURY 5 0.0002
264 HYPOCALCAEMIA 3 0.0002
265 HYPOPHAGIA 4 0.0002
266 HEPATITIS ACUTE 1 0.0002
267 MENINGITIS 1 0.0001
268 HAIR TEXTURE ABNORMAL 2 0.0001
269 PAIN OF SKIN 4 0.0001
270 COLITIS ISCHAEMIC 1 0.0001
271 HYPOXIA 5 0.0001
272 LYMPHADENOPATHY 5 0.0001
273 ADVERSE EVENT 13 0.0001
274 LIVER FUNCTION TEST INCREASED 3 0.0001
275 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
276 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
277 DERMATITIS BULLOUS 1 0.0001
278 MOUTH HAEMORRHAGE 1 0.0001
279 BLOOD PRESSURE DECREASED 9 0.0001
280 HYPOPHOSPHATAEMIA 1 0.0001
281 ORAL PAIN 3 0.0001
282 PARAESTHESIA 21 0.0001
283 HYPOAESTHESIA ORAL 2 0.0001
284 COLITIS 5 0.0001
285 ACNE 10 0.0001
286 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
287 TROPONIN INCREASED 1 0.0001
288 PERICARDIAL EFFUSION 3 0.0001
289 FEMUR FRACTURE 4 0.0001
290 EJECTION FRACTION DECREASED 2 0.0001
291 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
292 PNEUMOTHORAX 2 0.0001
293 SENSORY LOSS 1 0.0001
294 NEURALGIA 3 0.0001
295 LUNG DISORDER 6 0.0001
296 ABNORMAL FAECES 1 0.0001
297 HICCUPS 1 0.0001
298 DECREASED APPETITE 28 0.0001
299 PNEUMONIA ASPIRATION 3 0.0001
300 EOSINOPHIL COUNT INCREASED 1 0.0001
301 SKIN PLAQUE 1 0.0001
302 HAEMATEMESIS 3 0.0001
303 SKIN HYPERPIGMENTATION 1 0.0001
304 NEOPLASM PROGRESSION 4 0.0001
305 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
306 NEUROTOXICITY 2 0.0001
307 TUMOUR LYSIS SYNDROME 1 0.0001
308 IMMUNOSUPPRESSION 1 0.0001
309 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
310 LIVER DISORDER 5 0.0001
311 CARDIOTOXICITY 1 0.0001
312 LEUKOCYTOSIS 2 0.0001
313 LIP DRY 1 0.0001
314 PNEUMONIA BACTERIAL 1 0.0001
315 HAEMATOCHEZIA 6 0.0001
316 WOUND 3 0.0001
317 ERYTHEMA MULTIFORME 1 0.0001
318 APPENDICITIS 1 0.0001
319 SPINAL DISORDER 1 0.0001
320 HYPERSOMNIA 3 0.0001
321 LIVER FUNCTION TEST ABNORMAL 3 0.0001
322 DYSPHONIA 6 0.0001
323 HOSPICE CARE 1 0.0001
324 SYNCOPE 10 0.0001
325 BLOOD POTASSIUM DECREASED 3 0.0001
326 CYTOKINE RELEASE SYNDROME 2 0.0001
327 THROMBOSIS 8 0.0001
328 CELLULITIS 5 0.0001
329 TASTE DISORDER 2 0.0001
330 BONE MARROW FAILURE 2 0.0001
331 EYELID PTOSIS 1 0.0001
332 FLUSHING 10 0.0001
333 MOTOR DYSFUNCTION 1 0.0001
334 RIB FRACTURE 2 0.0001
335 PETECHIAE 1 0.0001
336 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
337 TRANSFUSION 1 0.0001
338 RENAL IMPAIRMENT 8 0.0001
339 MOUTH ULCERATION 2 0.0001
340 HYPOTENSION 19 0.0001
341 FULL BLOOD COUNT ABNORMAL 1 0.0001
342 HYPOAESTHESIA 14 0.0001
343 SKIN LACERATION 1 0.0001
344 PULMONARY THROMBOSIS 1 0.0001
345 OESOPHAGITIS 1 0.0001
346 PRURITUS 35 0.0001
347 STAPHYLOCOCCAL INFECTION 3 0.0001
348 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
349 NEPHROPATHY TOXIC 1 0.0001
350 FISTULA 1 0.0001
351 BLOOD CALCIUM DECREASED 1 0.0001
352 CHROMATURIA 2 0.0001
353 CHEST DISCOMFORT 9 0.0001
354 MUSCLE SPASMS 16 0.0001
355 SKIN DISCOLOURATION 4 0.0001
356 NEOPLASM 1 0.0001
357 SHOCK 2 0.0001
358 EYELID OEDEMA 1 0.0001
359 OCULAR HYPERAEMIA 4 0.0001
360 BLOOD IRON DECREASED 1 0.0001
361 BACTERAEMIA 1 0.0001
362 ATAXIA 1 0.0001
363 ERYTHEMA 17 0.0001
364 C-REACTIVE PROTEIN INCREASED 3 0.0001
365 ADRENAL INSUFFICIENCY 1 0.0001
366 NOCTURIA 1 0.0001
367 HYPERGLYCAEMIA 3 0.0001
368 CEREBRAL INFARCTION 2 0.0001
369 GENERALISED OEDEMA 1 0.0001
370 PHARYNGITIS 1 0.0001
371 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
372 ILEUS 1 0.0001
373 TOOTH EXTRACTION 1 0.0001
374 DRY EYE 4 0.0001
375 SECRETION DISCHARGE 1 0.0001
376 MUSCULAR WEAKNESS 9 0.0001
377 BRAIN OEDEMA 1 0.0001
378 FLUID RETENTION 4 0.0001
379 INJECTION SITE IRRITATION 1 0.0001
380 HEPATIC CYTOLYSIS 1 0.0001
381 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
382 PERIPHERAL SWELLING 12 0.0001
383 ANAPHYLACTIC SHOCK 2 0.0001
384 BLOOD CREATININE INCREASED 5 0.0001
385 DEAFNESS 2 0.0001
386 ECZEMA 4 0.0001
387 ORAL CANDIDIASIS 1 0.0001
388 PULMONARY CONGESTION 1 0.0001
389 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
390 SARS-COV-2 TEST POSITIVE 1 0.0001
391 EYE HAEMORRHAGE 1 0.0001
392 BLOOD BILIRUBIN INCREASED 2 0.0001
393 THROAT TIGHTNESS 2 0.0001
394 RASH PRURITIC 4 0.0001
395 TACHYPNOEA 1 0.0001
396 GINGIVAL BLEEDING 1 0.0001
397 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
398 MENTAL STATUS CHANGES 2 0.0001
399 APHONIA 1 0.0001
400 DEMENTIA 2 0.0001
401 BLOOD TEST ABNORMAL 1 0.0001
402 SKIN EXFOLIATION 6 0.0001
403 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
404 HYPONATRAEMIA 4 0.0001
405 PARALYSIS 1 0.0001
406 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
407 HYPOKINESIA 1 0.0001
408 OFF LABEL USE 60 0.0001
409 DYSSTASIA 2 0.0001
410 BONE PAIN 4 0.0001
411 PULMONARY OEDEMA 3 0.0001
412 HAEMORRHAGE 7 0.0001
413 ADVERSE DRUG REACTION 6 0.0001
414 HOT FLUSH 5 0.0001
415 HEPATIC FAILURE 2 0.0001
416 ANKLE FRACTURE 1 0.0001
417 COGNITIVE DISORDER 3 0.0001
418 CONSTIPATION 14 0.0001
419 BRAIN FOG 1 0.0001
420 DIARRHOEA 41 0.0001
421 ANAEMIA 12 0.0001
422 THROMBOCYTOPENIA 7 0.0001
423 SENSORY DISTURBANCE 1 0.0001
424 PHOTOSENSITIVITY REACTION 1 0.0001
425 FACE OEDEMA 1 0.0001
426 FATIGUE 46 0.0001
427 MYALGIA 10 0.0001
428 HOSPITALISATION 9 0.0001
429 PYREXIA 20 0.0001
430 DELIRIUM 2 0.0001
431 ORTHOSTATIC HYPOTENSION 1 0.0001
432 HEART RATE DECREASED 2 0.0001
433 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
434 BRADYCARDIA 3 0.0001
435 HEAD DISCOMFORT 1 0.0001
436 CEREBRAL HAEMORRHAGE 2 0.0001
437 PELVIC PAIN 1 0.0001
438 DIZZINESS 27 0.0001
439 EYE PAIN 3 0.0001
440 PHOTOPHOBIA 1 0.0001
441 DYSPHAGIA 5 0.0001
442 GASTRIC ULCER 1 0.0001
443 PROTEINURIA 1 0.0001
444 INCREASED APPETITE 1 0.0001
445 ACUTE KIDNEY INJURY 8 0.0001
446 LOWER LIMB FRACTURE 1 0.0001
447 EAR PAIN 1 0.0001
448 DYSPNOEA 29 0.0001
449 KIDNEY INFECTION 1 0.0001
450 WHEEZING 3 0.0001
451 BLOOD PRESSURE ABNORMAL 1 0.0001
452 PRESCRIBED UNDERDOSE 1 0.0001
453 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
454 FEELING HOT 3 0.0000
455 RHABDOMYOLYSIS 2 0.0000
456 URTICARIA 8 0.0000
457 PLATELET COUNT DECREASED 5 0.0000
458 LOSS OF CONSCIOUSNESS 6 0.0000
459 RECTAL HAEMORRHAGE 2 0.0000
460 SKIN CANCER 1 0.0000
461 PRODUCT PRESCRIBING ISSUE 1 0.0000
462 NAUSEA 36 0.0000
463 TRANSAMINASES INCREASED 1 0.0000
464 RASH MACULO-PAPULAR 1 0.0000
465 GLOSSODYNIA 1 0.0000
466 HEPATIC ENZYME INCREASED 3 0.0000
467 MUSCLE TWITCHING 1 0.0000
468 HYPOKALAEMIA 2 0.0000
469 CHEST PAIN 8 0.0000
470 BACK PAIN 10 0.0000
471 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
472 DISEASE PROGRESSION 5 0.0000
473 ARRHYTHMIA 2 0.0000
474 DRUG INTOLERANCE 4 0.0000
475 PRESYNCOPE 1 0.0000
476 ATRIAL FIBRILLATION 4 0.0000
477 ENCEPHALOPATHY 1 0.0000
478 VOMITING 19 0.0000
479 LEUKOPENIA 2 0.0000
480 ASTHENIA 15 0.0000
481 HEPATITIS 1 0.0000
482 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
483 HYPERHIDROSIS 5 0.0000
484 DIPLOPIA 1 0.0000
485 RESPIRATORY TRACT INFECTION 1 0.0000
486 GASTRITIS 1 0.0000
487 DEHYDRATION 5 0.0000
488 CARDIAC FAILURE 3 0.0000
489 PALLOR 1 0.0000
490 MOOD ALTERED 1 0.0000
491 TREATMENT NONCOMPLIANCE 2 0.0000
492 VISION BLURRED 5 0.0000
493 DIVERTICULITIS 1 0.0000
494 FEELING COLD 1 0.0000
495 SEPSIS 4 0.0000
496 HAEMOPTYSIS 1 0.0000
497 NECK PAIN 2 0.0000
498 COUGH 10 0.0000
499 BLISTER 2 0.0000
500 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
501 HERPES ZOSTER 2 0.0000
502 MUSCULOSKELETAL STIFFNESS 3 0.0000
503 MALAISE 15 0.0000
504 CHILLS 4 0.0000
505 NASAL CONGESTION 2 0.0000
506 ASCITES 1 0.0000
507 ACUTE MYOCARDIAL INFARCTION 1 0.0000
508 PSYCHOTIC DISORDER 1 0.0000
509 TACHYCARDIA 3 0.0000
510 CATARACT 2 0.0000
511 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
512 LIMB DISCOMFORT 1 0.0000
513 NERVOUS SYSTEM DISORDER 1 0.0000
514 SWOLLEN TONGUE 1 0.0000
515 HEAD INJURY 1 0.0000
516 PRODUCT DOSE OMISSION ISSUE 9 0.0000
517 ALOPECIA 6 0.0000
518 DYSPEPSIA 3 0.0000
519 IMPAIRED HEALING 1 0.0000
520 HEADACHE 19 0.0000
521 HEART RATE INCREASED 3 0.0000
522 VISUAL ACUITY REDUCED 1 0.0000
523 URINARY RETENTION 1 0.0000
524 GAIT INABILITY 1 0.0000
525 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
526 NEUTROPENIA 4 0.0000
527 ABDOMINAL DISTENSION 3 0.0000
528 PNEUMONIA 9 0.0000
529 PAIN 17 0.0000
530 INFECTION 4 0.0000
531 DYSURIA 1 0.0000
532 PAIN IN EXTREMITY 8 0.0000
533 FALL 9 0.0000
534 EYE SWELLING 1 0.0000
535 WEIGHT INCREASED 6 0.0000
536 DYSPNOEA EXERTIONAL 1 0.0000
537 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
538 PALPITATIONS 3 0.0000
539 WEIGHT DECREASED 7 0.0000
540 CARDIAC FAILURE CONGESTIVE 2 0.0000
541 SOMNOLENCE 5 0.0000
542 BLINDNESS 1 0.0000
543 NEUTROPHIL COUNT DECREASED 1 0.0000
544 LUNG NEOPLASM MALIGNANT 1 0.0000
545 ABDOMINAL PAIN UPPER 5 0.0000
546 INJECTION SITE ERYTHEMA 3 0.0000
547 POLLAKIURIA 1 0.0000
548 CARDIO-RESPIRATORY ARREST 1 0.0000
549 ABDOMINAL DISCOMFORT 4 0.0000
550 BALANCE DISORDER 2 0.0000
551 SEPTIC SHOCK 1 0.0000
552 COLITIS ULCERATIVE 1 0.0000
553 GASTROINTESTINAL DISORDER 2 0.0000
554 THROAT IRRITATION 1 0.0000
555 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
556 OROPHARYNGEAL PAIN 2 0.0000
557 ABDOMINAL PAIN 5 0.0000
558 SWELLING 2 0.0000
559 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
560 CONTUSION 2 0.0000
561 HYPOGLYCAEMIA 1 0.0000
562 ILLNESS 2 0.0000
563 ARTHRALGIA 8 0.0000
564 NERVOUSNESS 1 0.0000
565 MUSCULOSKELETAL PAIN 1 0.0000
566 DERMATITIS ATOPIC 1 0.0000
567 ANAPHYLACTIC REACTION 1 0.0000
568 TREMOR 3 0.0000
569 INFLUENZA 2 0.0000
570 PANCYTOPENIA 1 0.0000
571 CEREBROVASCULAR ACCIDENT 3 0.0000
572 DEPRESSION 4 0.0000
573 EYE IRRITATION 1 0.0000
574 MYOCARDIAL INFARCTION 3 0.0000
575 SURGERY 1 0.0000
576 IRRITABILITY 1 0.0000
577 HYPERSENSITIVITY 3 0.0000
578 VISUAL IMPAIRMENT 2 0.0000
579 RHINORRHOEA 1 0.0000
580 INJECTION SITE PRURITUS 1 0.0000
581 BURNING SENSATION 1 0.0000
582 SLEEP DISORDER 1 0.0000
583 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
584 SKIN BURNING SENSATION 1 0.0000
585 RESPIRATORY FAILURE 1 0.0000
586 UNDERDOSE 1 0.0000
587 DYSGEUSIA 1 0.0000
588 BLOOD PRESSURE INCREASED 2 0.0000
589 DRUG INTERACTION 2 0.0000
590 INJECTION SITE BRUISING 1 0.0000
591 FEELING ABNORMAL 3 0.0000
592 DRY MOUTH 1 0.0000
593 INFLUENZA LIKE ILLNESS 1 0.0000
594 DEATH 10 0.0000
595 PRODUCT STORAGE ERROR 1 0.0000
596 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
597 NASOPHARYNGITIS 2 0.0000
598 CARDIAC DISORDER 1 0.0000
599 GAIT DISTURBANCE 2 0.0000
600 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
601 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
602 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
603 ASTHMA 1 0.0000
604 SEIZURE 1 0.0000
605 JOINT SWELLING 1 0.0000
606 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
607 RENAL FAILURE 1 0.0000
608 ANXIETY 2 0.0000
609 COVID-19 1 0.0000
610 NO ADVERSE EVENT 1 0.0000
611 PRODUCT USE ISSUE 1 0.0000
612 BLOOD GLUCOSE INCREASED 1 0.0000
613 HYPERTENSION 1 0.0000
614 OVERDOSE 1 0.0000
615 DRUG INEFFECTIVE 3 0.0000